When patients are about to start treatment for osteoporosis,
one concern comes up again and again.
Jaw osteonecrosis.
After searching online, many people come to the clinic worried.
“I read that osteoporosis medication can make the jaw rot.”
“Someone said dental treatment can cause serious problems.”
Because of this, I often hear the same question in the exam room:
“Doctor, if I take this medication, will my jaw be damaged?”
Today, I’d like to explain this issue calmly and honestly —
using real numbers, without exaggeration,
so you can understand how common this problem truly is.
What Is Jaw Osteonecrosis?
Jaw osteonecrosis (ONJ — osteonecrosis of the jaw) is defined as:
- exposure of jaw bone inside the mouth
- that persists for more than 8 weeks
In most cases, it is identified when:
- the gum does not heal properly after tooth extraction or implant surgery
- and the jaw bone remains exposed for an extended period
This definition is important —
a slow-healing gum alone does not mean osteonecrosis.
How Is It Related to Osteoporosis Medications?
Jaw osteonecrosis has been reported in association with
medications that suppress bone resorption.
The most common examples include:
- Bisphosphonates (BP medications)
- Prolia (denosumab)
These drugs play a very important role in osteoporosis treatment.
They help prevent bones from becoming fragile
and significantly reduce the risk of fractures.
In very rare cases, however, strong suppression of bone turnover may:
- slow normal jaw bone healing
- especially after invasive dental procedures
For this reason, jaw osteonecrosis has been reported in association with these medications.
Importantly, this does not mean the medication directly “causes” the condition —
only that a relationship has been observed.
The Most Important Question
“How often does this actually happen?”
This is what most patients truly want to know.
■ Risk at standard osteoporosis treatment doses
- Estimated incidence: approximately 0.001–0.01%
- In practical terms: about 1 in several thousand to tens of thousands of patients
In other words,
The vast majority of people who take osteoporosis medication
will never experience jaw osteonecrosis —
even with long-term treatment.
Why Does It Sound So Much Scarier Online?
There is a clear reason.
Jaw osteonecrosis occurs far more frequently in:
- cancer patients
- receiving very high-dose antiresorptive therapy
- as part of chemotherapy or metastatic bone treatment
These doses are many times higher than those used for osteoporosis.
However, online articles often mix:
- cancer-related cases
- and routine osteoporosis treatment
without clearly separating the two.
As a result, the perceived risk becomes much larger than the real one.
Should Osteoporosis Medication Be Stopped Before Dental Treatment?
This is another very common question.
The short answer is:
✖ Not for most dental procedures.
For routine care such as:
- dental cleaning
- cavity treatment
- regular checkups
osteoporosis medication usually does not need to be stopped.
However, for invasive procedures such as:
- tooth extraction
- dental implants
- gum surgery
it is best to coordinate timing between:
- your dentist
- and your treating physician
This approach allows treatment to be planned safely.
Which Is More Dangerous: Medication Side Effects or Fractures?
This question is extremely important.
In older adults, fractures — especially:
- hip fractures
- spinal compression fractures
can lead to:
- loss of mobility
- reduced independence
- prolonged bed rest
- pneumonia, pressure sores, delirium
- and in some cases, increased mortality
These complications are very common in real clinical practice.
In contrast, jaw osteonecrosis:
- is extremely rare
- occurs in a very small fraction of patients
For most individuals, the benefit of preventing fractures
far outweighs the small risk of this complication.
How Can You Lower the Risk of Jaw Osteonecrosis?
Simple steps make a big difference:
- dental evaluation before starting medication
- good daily oral hygiene
- informing your doctor in advance of planned dental procedures
Following these principles keeps the risk very low.
Summary
- Jaw osteonecrosis related to osteoporosis medication is very rare
- Estimated risk is about 1 in several thousand to tens of thousands
- Most cases occur with high-dose cancer therapy, not osteoporosis treatment
- Routine dental care does not usually require stopping medication
- In most patients, fracture prevention provides far greater benefit
A Final Message
Reading about jaw osteonecrosis online can easily increase anxiety.
But in everyday clinical practice,
this complication is encountered very infrequently.
Osteoporosis treatment should not be delayed out of fear.
It is not a treatment to avoid —
but one to manage carefully and thoughtfully to prevent fractures.
If you have concerns,
the safest and most reliable source of guidance
is not online forums, but a direct conversation with your physician.
Leave a Reply